Matches in SemOpenAlex for { <https://semopenalex.org/work/W2069080908> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W2069080908 endingPage "53" @default.
- W2069080908 startingPage "343" @default.
- W2069080908 abstract "This article delineates the conceptual models used when medications are prescribed for patients with personality disorders and reviews the data on the efficacy of these medications. Studies before 1980 are difficult to interpret because of changes in diagnostic criteria. Nonetheless, early studies on non-DSM-III disorders such as pseudoneurotic schizophrenia, emotionally unstable character disorder, hysteroid dysphoria, and subaffective disorders indicated the potential utility of pharmacotherapy for treating personality disorders. Models to consider in evaluating the possible use of medications for treating personality disorders are: (1) treating the disorder itself; (2) treating symptom clusters within and across disorders; and (3) treating associated axis I disorders. Among the current personality disorders, borderline personality disorder has been the most extensively studied, with antipsychotic agents being the most well-documented treatment. Monoamine oxidase inhibitors, fluoxetine, and carbamazepine show promise. Schizotypal disorders may respond to low-dose antipsychotic drugs. Although heuristically valuable, the symptom cluster approach to treatment has not yet been validated. Axis I disorders, especially depression, are frequently associated with all personality disorders. Dependent personality disorder is linked to panic disorder with agoraphobia, whereas avoidant personality disorder is associated with social phobia and panic. In general, pharmacotherapy for axis I disorders is less effective in the presence of a comorbid personality disorder. Despite the modest benefits seen in many studies, pharmacotherapy can add significantly to the overall treatment of those with personality disorders. Future research must carefully assess the effect of comorbid axis I disorders on responses. The symptom cluster/psychobiologic dimension approach should be investigated in clinical studies." @default.
- W2069080908 created "2016-06-24" @default.
- W2069080908 creator A5010205978 @default.
- W2069080908 date "1993-10-01" @default.
- W2069080908 modified "2023-09-25" @default.
- W2069080908 title "Pharmacotherapy of personality disorders: conceptual framework and clinical strategies." @default.
- W2069080908 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8227492" @default.
- W2069080908 hasPublicationYear "1993" @default.
- W2069080908 type Work @default.
- W2069080908 sameAs 2069080908 @default.
- W2069080908 citedByCount "8" @default.
- W2069080908 crossrefType "journal-article" @default.
- W2069080908 hasAuthorship W2069080908A5010205978 @default.
- W2069080908 hasConcept C118552586 @default.
- W2069080908 hasConcept C145734003 @default.
- W2069080908 hasConcept C15744967 @default.
- W2069080908 hasConcept C187288502 @default.
- W2069080908 hasConcept C2776412080 @default.
- W2069080908 hasConcept C2777308609 @default.
- W2069080908 hasConcept C2777529043 @default.
- W2069080908 hasConcept C2778678127 @default.
- W2069080908 hasConcept C2779354729 @default.
- W2069080908 hasConcept C2780600973 @default.
- W2069080908 hasConcept C32846899 @default.
- W2069080908 hasConcept C500440147 @default.
- W2069080908 hasConcept C558461103 @default.
- W2069080908 hasConcept C70410870 @default.
- W2069080908 hasConcept C77805123 @default.
- W2069080908 hasConcept C8597951 @default.
- W2069080908 hasConceptScore W2069080908C118552586 @default.
- W2069080908 hasConceptScore W2069080908C145734003 @default.
- W2069080908 hasConceptScore W2069080908C15744967 @default.
- W2069080908 hasConceptScore W2069080908C187288502 @default.
- W2069080908 hasConceptScore W2069080908C2776412080 @default.
- W2069080908 hasConceptScore W2069080908C2777308609 @default.
- W2069080908 hasConceptScore W2069080908C2777529043 @default.
- W2069080908 hasConceptScore W2069080908C2778678127 @default.
- W2069080908 hasConceptScore W2069080908C2779354729 @default.
- W2069080908 hasConceptScore W2069080908C2780600973 @default.
- W2069080908 hasConceptScore W2069080908C32846899 @default.
- W2069080908 hasConceptScore W2069080908C500440147 @default.
- W2069080908 hasConceptScore W2069080908C558461103 @default.
- W2069080908 hasConceptScore W2069080908C70410870 @default.
- W2069080908 hasConceptScore W2069080908C77805123 @default.
- W2069080908 hasConceptScore W2069080908C8597951 @default.
- W2069080908 hasIssue "5" @default.
- W2069080908 hasLocation W20690809081 @default.
- W2069080908 hasOpenAccess W2069080908 @default.
- W2069080908 hasPrimaryLocation W20690809081 @default.
- W2069080908 hasRelatedWork W2026251305 @default.
- W2069080908 hasRelatedWork W2045643312 @default.
- W2069080908 hasRelatedWork W2069080908 @default.
- W2069080908 hasRelatedWork W2071600260 @default.
- W2069080908 hasRelatedWork W2189020397 @default.
- W2069080908 hasRelatedWork W2396835381 @default.
- W2069080908 hasRelatedWork W2408994151 @default.
- W2069080908 hasRelatedWork W2417880992 @default.
- W2069080908 hasRelatedWork W3140001588 @default.
- W2069080908 hasRelatedWork W2773823381 @default.
- W2069080908 hasVolume "13" @default.
- W2069080908 isParatext "false" @default.
- W2069080908 isRetracted "false" @default.
- W2069080908 magId "2069080908" @default.
- W2069080908 workType "article" @default.